About this trial
Primary Aim: Assess improvement in ergonomics and musculoskeletal discomfort with the Surgistep compared to a standard footstool.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Regularly perform neurosurgical procedures (cranial/spine)
Willing to use both devices (multiple times each).
Disqualifiers
Severe MSK conditions preventing device usage
Inability/refusal to participate in observation or surveys.
Trial design
Crossover
Treatments tested in this trial
SurgiStep Platform
DeviceThe Surgistep (pedal-controlled, adjustable platform) allows real-time height adjustment during surgery. The surgeons can adjust the height of the platform.
Standard Foot stool
DeviceFoot stool is considered as the standard of care during surgery.
Treatment groups
Trial outcomes
Primary outcomes
Rapid Entire Body Assessment (REBA) Scale Score
The REBA (Rapid Entire Body Assessment) score, used to assess the risk of musculoskeletal disorders (MSDs) in work tasks, ranges from 1 to 15. A lower REBA score indicates a lower risk, with scores below 4 considered to have minimal risk. Higher scores indicate increased risk, with scores of 8 or more indicating a high risk that requires immediate attention and intervention
Rapid Upper Limb Assessment (RULA) Scale Score
The RULA (Rapid Upper Limb Assessment) scale ranges from 1 to 7, with lower scores indicating lower risk and higher scores indicating higher risk of musculoskeletal disorders.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: